AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2011:12 ANNUAL REPORT
TABLE OF CONTENTS
Letter of transmittal 3
About this report 4
Message from the CEO 10
Chapter 1: Organisational overview 17
About ASADA 18
Legislative basis 18
Role and functions 18
Goals 19
Australia’s anti‑doping structure 19
Outcome and program structure 21
Highlights of 2011–12 22
Chapter 2: Report on performance 25
Program 1.1 – Deterrence, detection and enforcement 26
Deliverables 26
Key performance indicators 28
Building awareness 30
Digital marketing 30
Communication campaigns 31
Media 32
Printed resources 34
Education 35
Partnerships 38
Assisting sporting organisations 39
Sports forums 39
Liaison with national sporting bodies 39
International engagement 39
Review of the World Anti‑Doping Code 41
Review of draft Prohibited List 41
WADA Symposium for Anti‑Doping Organisations 41
Institute of National Anti‑Doping Organisations (iNADO) 42
International Anti‑Doping Arrangement (IADA) 42
Monitoring Group for the Council of Europe 42
Third Session of the Conference of Parties to the International Convention Against Doping in Sport 43
Oceania Regional Anti‑Doping Organisation (ORADO) 43
International visitors 43
Detection 44
National testing and sport operations program 45
Sample collection 45
Pure Performance programs 45
User‑pays tests 46
Long‑term storage facility 47
Accreditation of Doping Control Officers and Chaperones 47
Investigations and intelligence 48
Athlete whereabouts 48
Enforcement 49
Athlete counselling service 51
Chapter 3: Management and accountability 53
Corporate governance 54
Corporate and operational planning 54
Organisational structure and senior executive arrangements 55
Governance committees 56
Risk management 57
Ethical standards 59
Internal audits 60
Records management 60
Quality management 61
External scrutiny 62
Significant developments 62
Decisions and reports 62
Management of human resources 62
Workforce planning 63
Attraction and retention 63
Employment agreements 63
Section 24(1) determinations 64
Non‑salary benefits 64
Performance management system 64
Australia Day medallion 64
Peer recognition 65
Staff consultation 65
Survey 65
Learning and development 65
Workplace diversity 66
Commonwealth Disability Strategy 66
Work health and safety 67
Chapter 4: Financial information 69
Summary of financial performance 2011–12 70
Grant programs 70
Asset management 70
Purchasing 71
Engagement of consultants and contractors 71
Consultants 71
Competitive tendering and contracting 72
Auditor-General access 72
Exempt contracts 72
Chapter 5: Financial statements 75
Chapter 6: ASADA Advisory Group 129
Overview 130
Members 130
Resources 131
Chapter 7: Anti‑Doping Rule Violation Panel 133
Overview 134
Functions 134
Members 134
Resources 135
Chapter 8: Australian Sports Drug Medical Advisory Committee 137
Overview 138
Functions 138
Clause 5.01 NAD scheme – functions of ASDMAC 138
Therapeutic approvals for prohibited substances 139
Members 139
Resources 141
Therapeutic Use Exemptions granted 141
Freedom of information – ASDMAC 145
Chapter 9: Appendixes 147
Appendix A: Doping control statistics 2001–02 to 2011–12 148
Appendix B: Publicly announced anti‑doping rule violations 2011–12 149
Appendix C: International anti‑doping and doping control 151
Appendix D: Powers of the Minister to give directions to the ASADA CEO 152
Appendix E: ASADA and CEO functions, powers and delegations 153
Appendix F: Staffing statistics at 30 June 2012 155
Appendix G: Work health and safety 157
Appendix H: Advertising and market research 158
Appendix I: Ecologically sustainable development and environmental performance 159
Appendix J: Freedom of information 160
Appendix K: Expenses and resources for Outcome 1 161
Appendix L: ASADA Resource Statement 2011–12 162
Chapter 10: Abbreviations and glossary 165
List of abbreviations 166
Glossary 168
Chapter 11: Indexes 173
Compliance index 174
Alphabetical index 178
LIST OF FIGURES
Figure 1: Australia’s anti‑doping framework 20
Figure 2: Outcome and program structure 2011–12 21
Figure 3: Number of athletes and support personnel recording anti‑doping rule violations 50
Figure 4: Organisational structure at 30 June 2012 56
LIST OF TABLES
Table 1: Program 1.1 qualitative deliverables 26
Table 2: Program 1.1 quantitative deliverables 27
Table 3: Program 1.1 qualitative key performance indicators 28
Table 4: Program 1.1 quantitative key performance indicators 29
Table 5: Education activities undertaken during 2011–12 37
Table 6: Satisfaction with ASADA education 38
Table 7: Anti‑doping tests conducted by ASADA in 2011–12 46
Table 8: Doping control facts and figures 2011–12 47
Table 9: Substances involved in anti‑doping matters 2011–12 49
Table 10: Breakdown of anti‑doping rule violations 2011–12 50
Table 11: Trends in consultancies 71
Table 12: Advisory Group attendance 2011–12 131
Table 13: Advisory Group expenses 2011–12 131
Table 14: ADRVP attendance 2011–12 135
Table 15: ADRVP expenses 2011–12 135
Table 16: ASDMAC members 141
Table 17: ASDMAC expenses 2011–12 141
Table 18: Therapeutic Use Exemptions granted 141
Table 19: Substances and methods approved for therapeutic use 2011–12 144
Table 20: ASDMAC freedom of information statistics 145
Table 21: Doping control statistics 148
Table 22: Publicly announced anti‑doping rule violations 149
Table 23: Entries on Register of Findings 2010–11 where the outcomes were to be advised 150
Table 24: Government‑to‑government arrangements 151
Table 25: Full‑time, part‑time and casual staff at 30 June 2012 155
Table 26: On‑going, non‑ongoing and casual staff by classification groups and location at 30 June 2012 155
Table 27: SES staff at 30 June 2012 155
Table 28: Staff in equal employment opportunity groups at 30 June 2012 156
Table 29: Salary ranges of employees 156
Table 30: Number of staff in the collective agreement or section 24(1) determinations 156
Table 31: Advertising and market research 158
Table 32: ASADA freedom of information statistics 160
Table 33: Expenses and resources for Outcome 1 161
Table 34: ASADA Resource Statement 162
